Skip to Content
Shadow

Press Releases

Press Releases

Date Title and Summary Additional Formats
Toggle Summary Agile Therapeutics Announces Peer-Reviewed Publication of Phase 3 SECURE Study Results for Twirla® (levonorgestrel and ethinyl estradiol) Transdermal System in Contraception
PRINCETON, N.J. , Nov. 30, 2020 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today announced that Contraception , an international, peer-reviewed, reproductive health journal, published the primary safety, efficacy, and tolerability results from the...
Toggle Summary Agile Therapeutics to Participate in the 32nd Annual Piper Sandler Healthcare Conference
PRINCETON, N.J. , Nov. 23, 2020 (GLOBE NEWSWIRE) -- Agile Therapeutics , Inc. (Nasdaq: AGRX), a women's healthcare company, today announced that Al Altomari , Chairman and Chief Executive Officer, will participate in a virtual fireside chat at the Piper Sandler 32 nd Annual Healthcare Conference,...
Toggle Summary Agile Therapeutics Reports Third Quarter 2020 Financial Results
Commercial Launch of Twirla ® Expected by Year-End 2020 $71.9 Million in Cash, Cash Equivalents, and Marketable Securities as of September 30, 2020 Management to Host Conference Call today at 4:30 PM ET PRINCETON, N.J. , Nov. 12, 2020 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc....
Toggle Summary Agile Therapeutics to Host Third Quarter 2020 Financial Results Conference Call and Provide Corporate and Twirla® Commercial Updates on Thursday, November 12, 2020
Live Conference Call and Webcast at 4:30 p.m. ET PRINCETON, N.J. , Nov. 04, 2020 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today announced it will report third quarter 2020 financial results after the market close on Thursday, November 12, 2020 ....
Toggle Summary Agile Therapeutics to Present at the Oppenheimer Fall Healthcare Life Sciences & MedTech Summit
PRINCETON, N.J. , Sept. 22, 2020 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today announced that Chairman and CEO Al Altomari will be virtually presenting at the Oppenheimer Fall Healthcare Life Sciences & MedTech Summit on Wednesday, September 23,...
Toggle Summary Agile Therapeutics to Participate in Fireside Chat at the H.C. Wainwright 22nd Annual Global Investment Virtual Conference
PRINCETON, N.J. , Sept. 09, 2020 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a forward-thinking women’s healthcare company, today announced that Al Altomari , Chairman and Chief Executive Officer, will participate in a fireside chat at the H.C....
Toggle Summary Agile Therapeutics Announces Virtual Investor/Analyst Day on Monday, September 21, 2020
Company to Present Twirla ® Commercial Plan Webcast Scheduled from 11:00 am – 1:00 pm EDT PRINCETON, N.J. , Sept. 08, 2020 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today announced that it will host a virtual Investor/Analyst Day on Monday, September...
Toggle Summary Agile Therapeutics Launches I’m So Done Campaign to Inspire Women to Take an Active Role in Choosing their Birth Control
Visit  BirthControlDoneMyWay.com to learn more about some of the many available contraceptive options I’m So Done is a national unbranded campaign intended to enhance the birth control conversation for women Encourage education on contraceptive care options Facilitate an honest discussion between...
Toggle Summary Agile Therapeutics Strengthens Executive Leadership Team with the Appointment of Paul Korner, MD, MBA, as Chief Medical Officer
PRINCETON, N.J. , Aug. 17, 2020 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a forward-thinking women’s healthcare company, today announced the appointment of Paul Korner , MD, MBA, to the position of Chief Medical Officer. Dr. Korner is a board-certified obstetrician and...
Toggle Summary Agile Therapeutics to Participate in Maxim Group’s Leading Innovators in Women’s Health Virtual Conference
PRINCETON, N.J. , Aug. 11, 2020 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today announced that Al Altomari , Chairman and Chief Executive Officer, will participate in a panel discussion as part of Maxim Group’s M-Vest Virtual Conference Series:...
Shadow